Richard Sumich (@richardsumich) 's Twitter Profile
Richard Sumich

@richardsumich

Head of Communications & Public Affairs Johnson & Johnson Medical Devices Asia Pacific. Views and tweets my own.

ID: 23052436

calendar_today06-03-2009 10:55:18

454 Tweet

415 Takipçi

957 Takip Edilen

Johnson & Johnson MedTech (@jnjmedtech) 's Twitter Profile Photo

During the Meet the CEO Series at the APACMed Virtual Forum 2020, Asia Pacific Company Group Chairman Tim Schmid discusses his experience as a #MedTech leader in the region over the past ten months. #MedTechForum2020

During the Meet the CEO Series at the <a href="/APACMed/">APACMed</a> Virtual Forum 2020, Asia Pacific Company Group Chairman Tim Schmid discusses his experience as a #MedTech leader in the region over the past ten months. 

#MedTechForum2020
Johnson & Johnson MedTech (@jnjmedtech) 's Twitter Profile Photo

In our evolving healthcare landscape, the need for #MedTech agility has never been greater. We are proud to have played a role in today’s APACMed Virtual Forum 2020, affirming our commitment to saving lives and igniting all that’s possible in every-body. #MedTechForum2020

In our evolving healthcare landscape, the need for #MedTech agility has never been greater. We are proud to have played a role in today’s <a href="/APACMed/">APACMed</a> Virtual Forum 2020, affirming our commitment to saving lives and igniting all that’s possible in every-body. #MedTechForum2020
Johnson & Johnson MedTech (@jnjmedtech) 's Twitter Profile Photo

How do we drive much needed #MedTech innovation in Asia Pacific? Collaborating with MedTech Innovator to nurture talent and embrace MedTech disruption. bit.ly/3ighWm3 #JNJ #JNJMedicalDevices bit.ly/3cJFD50

How do we drive much needed #MedTech innovation in Asia Pacific? Collaborating with <a href="/MedTechAwards/">MedTech Innovator</a> to nurture talent and embrace MedTech disruption.  bit.ly/3ighWm3 #JNJ #JNJMedicalDevices bit.ly/3cJFD50
Richard Sumich (@richardsumich) 's Twitter Profile Photo

Something good today "These Benefits Hold Unique Value for the LGBTQIA+ Community": Zack's Adoption Journey careers.jnj.com/careers/these-… #MyCompany #JNJ #LGBTQ

Johnson & Johnson (@jnjnews) 's Twitter Profile Photo

Discover how experts are preparing for a second wave of #COVID19 and get an update on Phase Three clinical trials from Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D. Watch #JNJ “The Road to a Vaccine” LIVE Tuesday, October 6 at 12PM ET: bit.ly/2YTWgpB

Johnson & Johnson (@jnjnews) 's Twitter Profile Photo

Congrats to UC Berkeley professor, #DPJAward winner & #JNJ Board of Directors member Jennifer Doudna on winning the 2020 #NobelPrize in Chemistry with collaborator Emmanuelle Charpentier. Their accomplishments are a testament to the profound, transformative power of science.

Congrats to <a href="/UCBerkeley/">UC Berkeley</a> professor, #DPJAward winner &amp; #JNJ Board of Directors member Jennifer Doudna on winning the 2020 #NobelPrize in Chemistry with collaborator Emmanuelle Charpentier. Their accomplishments are a testament to the profound, transformative power of science.
Johnson & Johnson MedTech (@jnjmedtech) 's Twitter Profile Photo

#JNJMedicalDevices is committed to accelerating innovation to drive better outcomes for patients and customers. We are collaborating with MedTech Innovator to encourage robust #MedTech ideas. Watch to find out more: linkedin.com/feed/update/ur… #JNJ

Johnson & Johnson (@jnjnews) 's Twitter Profile Photo

The NIH has begun enrollment for ACTIV-1 IM, a Phase 3 study to evaluate the safety and efficacy of Johnson & Johnson's immune modulator for the treatment of #COVID19 in hospitalized patients. Learn more: bit.ly/3k677oi

The <a href="/NIH/">NIH</a> has begun enrollment for ACTIV-1 IM, a Phase 3 study to evaluate the safety and efficacy of Johnson &amp; Johnson's immune modulator for the treatment of #COVID19 in hospitalized patients. Learn more: bit.ly/3k677oi
The New York Times (@nytimes) 's Twitter Profile Photo

Breaking News: Pope Francis voiced support for civil union laws for same-sex couples, his strongest statement yet on the issue and a break with church doctrine. nyti.ms/2TdHmGT